中国实用医刊
中國實用醫刊
중국실용의간
Chinese Journal of Practical Medicine
2015年
24期
26-27
,共2页
急性早幼粒细胞白血病%三氧化二砷%化疗%联合治疗%临床疗效
急性早幼粒細胞白血病%三氧化二砷%化療%聯閤治療%臨床療效
급성조유립세포백혈병%삼양화이신%화료%연합치료%림상료효
Acute promyelocytic leukemia%Arsenic trioxide%Chemotherapy%Combination therapy%Clinical efficacy
目的 探讨采用三氧化二砷联合化疗对急性早幼粒细胞白血病进行治疗的临床效果和安全性.方法 随机选取商丘市第一人民医院2011年11月至2013年9月收治的急性早幼粒细胞白血病患者90例,按照治疗方法的不同将其随机分为实验组和对照组,对照组实施单纯化疗方案,实验组采用三氧化二砷联合化疗方案进行治疗,对比两组患者的临床治疗效果和不良反应的发生情况.结果 实验组临床疗效、生存状况均明显优于对照组(P＜0.05).结论 采用三氧化二砷联合化疗治疗急性早幼粒细胞白血病能够有效提高患者的生存质量,疗效显著.
目的 探討採用三氧化二砷聯閤化療對急性早幼粒細胞白血病進行治療的臨床效果和安全性.方法 隨機選取商丘市第一人民醫院2011年11月至2013年9月收治的急性早幼粒細胞白血病患者90例,按照治療方法的不同將其隨機分為實驗組和對照組,對照組實施單純化療方案,實驗組採用三氧化二砷聯閤化療方案進行治療,對比兩組患者的臨床治療效果和不良反應的髮生情況.結果 實驗組臨床療效、生存狀況均明顯優于對照組(P＜0.05).結論 採用三氧化二砷聯閤化療治療急性早幼粒細胞白血病能夠有效提高患者的生存質量,療效顯著.
목적 탐토채용삼양화이신연합화료대급성조유립세포백혈병진행치료적림상효과화안전성.방법 수궤선취상구시제일인민의원2011년11월지2013년9월수치적급성조유립세포백혈병환자90례,안조치료방법적불동장기수궤분위실험조화대조조,대조조실시단순화료방안,실험조채용삼양화이신연합화료방안진행치료,대비량조환자적림상치료효과화불량반응적발생정황.결과 실험조림상료효、생존상황균명현우우대조조(P＜0.05).결론 채용삼양화이신연합화료치료급성조유립세포백혈병능구유효제고환자적생존질량,료효현저.
Objective To investigate the clinical efficacy and safety of arsenic trioxide in combination with chemotherapy for treating acute promyelocytic leukemia.Methods Randomly selected 90 patients with acute promyelocytic leukemia admitted to hospital from November 2011 to September 2013 and randomly divided them into experiment group and control group according to different treatments.The control group was given chemotherapy merely, and the experiment group was treated with arsenic trioxide combination chemotherapy.The clinical effects and adverse reactions of the two groups were compared.Results The clinical efficacy, survival state of patients in the experiment group were significantly better than that in the control group (P ＜ 0.05).Conclusions Arsenic trioxide combined with chemotherapy in treatment of acute promyelocytic leukemia can effectively improve the quality of life of patients and has significant effect.
